/
Scheduling Actions Scheduling Actions

Scheduling Actions - PDF document

ruby
ruby . @ruby
Follow
343 views
Uploaded On 2021-09-24

Scheduling Actions - PPT Presentation

Chronological Order FINAL ORDER SUBSTANCE PROPOSAL FEDERAL Scheduled under 21 USC 811h PUBLICATION PUBLICATION REGISTER EFFECTIVE CSA DATEDATECITATION DATE SCHEDULE METHAMPHETAMINE 052671 0707 ID: 884887

fentanyl date indazole methyl date fentanyl methyl indazole phenethylpiperidin 2021 alpha 2020 order iii carboxamide publication fluoropentyl 2019 2016

Share:

Link:

Embed:

Download Presentation from below link

Download Pdf The PPT/PDF document "Scheduling Actions" is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.


Presentation Transcript

1 Scheduling Actions - Chronological Orde
Scheduling Actions - Chronological Order - FINAL ORDER SUBSTANCE PROPOSAL FEDERAL *Scheduled under 21 USC 811(h) PUBLICATION PUBLICATION REGISTER EFFECTIVE CSA DATE DATE CITATION DATE SCHEDULE METHAMPHETAMINE 05-26-71 07-07-71 36 FR 12734 7/7/1971 III ￿- II AMPHETAMINE 05-26-71 07-07-71 36 FR 12734 7/7/1971 III ￿- II FETAMIN 05-26-71 07-23-71 36 FR 13686 7/23/1971 III ￿- II BIPHETAMINE & BIPHETAMINE-T 05-26-71 07-23-71 36 FR 13686 7/23/1971 III ￿- II ESKATROL 05-26-71 08-18-71 36 FR 15744 8/18/1971 III ￿- II NALOXONE HYDROCHLORIDE 08-19-71 09-29-71 36 FR 19116 9/29/1971 II ￿- 0 METHYLPHENIDATE 09-17-71 10-28-71 36 FR 20686 10/28/1971 III ￿- II PHENMETRAZINE 09-17-71 10-28-71 36 FR 20686 10/28/1971 III ￿- II PROPIRAM 01-29-72 37 FR 1468 1/29/1972 I MAZINDOL 05-09-73 06-15-73 38 FR 15719 6/15/1973 III FENFLURAMINE 05-09-73 06-15-73 38 FR 15719 6/15/1973 IV PHENDIMETRAZINE 05-09-73 06-15-73 38 FR 15719 6/15/1973 III CLORTERMINE 05-09-73 06-15-73 38 FR 15719 6/15/1973 III CHLORPHENTERMINE 05-09-73 06-15-73 38 FR 15719 6/15/1973 III BENZPHETAMINE 05-09-73 06-15-73 38 FR 15719 6/15/1973 III PHENTERMINE 05-09-73 38 FR 18013 7/6/1973 IV DIETHYLPROPION 05-10-73 07-06-73 38 FR 18013 7/6/1973 IV DROTEBANOL 07-03-73 38 FR 17717 8/6/1973 I 4-BROMO-2,5-DIMETHOXYAMPHETAMINE 07-02-73 09-21-73 38 FR 26447 9/21/1973 I 2,5-DIMETHOXYAMPHETAMINE (DMA) 05-31-73 09-21-73 38 FR 26447 9/21/1973 I 4-METHOXYAMPHETAMINE (PMA) 07-02-73 09-21-73 38 FR 26447 9/21/1973 METHAQUALONE 04-11-73 10-04-73 38 FR 27516 10/4/1973 II SECOBARBITAL 05-31-73 11-13-73 38 FR 31310 11/13/1973 III ￿- II PENTOBARBITAL 05-31-75 11-13-73 38 FR 31310 11/13/1973 III ￿- II AMOBARBITAL 05-31-73 11-13-73 38 FR 31310 11/13/1973 III ￿- II ETORPHINE HYDROCHLORIDE 11-23-73 03-29-74 39 FR 11535 4/19/1974 I ￿- II NALOXONE 12-24-74 39 FR 44392 12/24/1974 II ￿- 0 PEMOLINE 11-07-74 01-28-75 40 FR 4150 1/28/1975 IV MEBUTAMATE 12-13-74 01-30-75 40 FR 4418 1/30/1975 IV CONCENTRATE OF POPPY STRAW 12-20-74 02-14-75 40 FR 6779 2/14/1975 II NALTREXONE 12-09-74 03-06-75 40 FR 10455 3/6/1975 II ￿- 0 Scheduling Actions -Chronological Order 27-Aug-21 Page 1 of 16 FINAL ORDER SUBSTANCE PROPOSAL FEDERAL *Scheduled under 21 USC 811(h) PUBLICATION PUBLICATION REGISTER EFFECTIVE CSA **Extension of temporary control DATE DATE CITATION DATE SCHEDULE DIFENOXIN 05-07-75 40 FR 19813 6/1/1975 I FLURA

2 ZEPAM 01-27-75 06-04-75 40 FR 23998
ZEPAM 01-27-75 06-04-75 40 FR 23998 7/2/1975 IV DIAZEPAM 01-27-75 06-04-75 40 FR 23998 7/2/1975 IV CLORAZEPATE 01-27-75 06-04-75 40 FR 23998 7/2/1975 IV CLONAZEPAM 01-27-75 06-04-75 40 FR 23998 7/2/1975 IV CHLORDIAZEPOXIDE 01-27-75 06-04-75 40 FR 23998 7/2/1975 IV OXAZEPAM 01-27-75 06-04-75 40 FR 23998 7/2/1975 IV MECLOQUALONE 05-29-75 07-08-75 40 FR 28611 7/10/1975 I TCP (PCP ANALOG) 05-29-75 07-08-75 40 FR 28611 8/11/1975 I MENRIUM 06-05-75 11-11-75 40 FR 52609 11/28/1975 Exempted RX LIBRAX 06-05-75 11-11-75 40 FR 52609 11/28/1975 Exempted RX APOMORPHINE 04-08-76 06-28-76 41 FR 26568 6/28/1976 II ￿- 0 DEXTRORPHAN 04-19-76 10-01-76 41 FR 43401 10/1/1976 I ￿- 0 NALBUPHINE 05-11-76 10-01-76 41 FR 43401 10/1/1976 II ￿- 0 PRAZEPAM 07-29-76 12-17-76 41 FR 55176 12/17/1976 IV DEXTROPROPOXYPHENE 09-29-76 02-11-77 42 FR 8636 3/14/1977 IV LOPERAMIDE 07-29-76 05-18-77 42 FR 25498 6/17/1977 V LORAZEPAM 06-28-77 10-07-77 42 FR 54546 10/3/1977 IV PHENCYCLIDINE (PCP) 12-19-77 01-25-78 43 FR 3359 2/24/1978 III ￿- II PCH (PCP PRECURSOR) 03-20-78 05-17-78 43 FR 21324 6/16/1978 II PCC (PCP PRECURSOR) 03-20-78 05-17-78 43 FR 21324 6/16/1978 II DIFENOXIN 1/2 MG WITH ATROPINE 06-26-78 08-28-78 43 FR 38382 9/27/1978 I ￿- V DIFENOXIN 1 MG WITH ATROPINE 06-26-78 08-28-78 43 FR 38382 9/27/1978 I ￿- IV PCE (PCP ANALOG) 08-11-78 09-25-78 43 FR 43295 10/25/1978 I PHP (PCP ANALOG) 08-11-78 09-25-78 43 FR 43295 10/25/1978 I PENTAZOCINE 09-13-78 01-10-79 44 FR 2169 2/9/1979 IV TILIDINE 09-30-80 45 FR 64571 1/12/1980 I PHENYLACETONE (P2P) 12-12-79 44 FR 71822 2/11/1980 II DEXTROPROPOXYPHENE 01-21-80 06-24-80 45 FR 42264 7/24/1980 IV DEXTROPROPOXYPHENE (BULK) 07-22-80 45 FR 48881 9/22/1980 IV ￿- II SPA (LEFETAMINE) 09-30-80 45 FR 64570 12/1/1980 IV PIPRADROL 09-30-80 45 FR 64570 12/1/1980 IV SUFENTANIL 09-30-80 45 FR 64571 12/1/1980 I TEMAZEPAM 01-05-81 04-07-81 45 FR 20671 4/7/1981 IV FENETHYLLINE 05-01-81 07-21-81 46 FR 37503 8/20/1981 I ALPHA-METHYLFENTANYL 08-05-81 09-22-81 46 FR 46799 9/22/1981 I HALAZEPAM 04-29-81 10-29-81 46 FR 53407 10/29/1981 IV Scheduling Actions -Chronological Order 27-Aug-21 Page 2 of 16 FINAL ORDER SUBSTANCE PROPOSAL FEDERAL *Scheduled under 21 USC 811(h) PUBLICATION PUBLICATION REGISTER EFFECTIVE CSA **Extension of temporary control DATE DATE CITATION DATE SCHEDULE ALPRAZOLAM 04-29-81 11-12-81 46 FR 55688 11/12/1981 IV MAZINDOL 04-17-8

3 1 10-27-81 46 FR 52333 11/27/1981 II
1 10-27-81 46 FR 52333 11/27/1981 III ￿- IV N-ETHYLAMPHETAMINE 09-10-81 12-08-81 46 FR 59969 1/7/1982 I LOPERAMIDE 07-28-82 11-03-82 47 FR 49840 11/3/1982 V -￿ 0 PARAHEXYL 08-05-82 11-22-82 47 FR 52432 12/22/1982 I TRIAZOLAM 04-29-81 12-28-82 47 FR 57694 12/28/1982 IV SUFENTANIL 03-20-84 05-25-84 49 FR 22074 5/25/1984 I ￿- II ALFENTANIL 06-25-84 49 FR 25849 8/24/1984 I METHAQUALONE 08-27-84 49 FR 33870 8/27/1984 II ￿- I PINAZEPAM 08-01-84 10-05-84 49 FR 39307 11/5/1984 IV NORDIAZEPAM 08-01-84 10-05-84 49 FR 39307 11/5/1984 IV NITRAZEPAM 08-01-84 10-05-84 49 FR 39307 11/5/1984 IV TETRAZEPAM 08-01-84 10-05-84 49 FR 39307 11/5/1984 IV OXAZOLAM 08-01-84 10-05-84 49 FR 39307 11/5/1984 IV LORMETAZEPAM 08-01-84 10-05-84 49 FR 39307 11/5/1984 IV ESTAZOLAM 08-01-84 10-05-84 49 FR 39307 11/5/1984 IV ETHYL LOFLAZEPATE 08-01-84 10-05-84 49 FR 39307 11/5/1984 IV DELORAZEPAM 08-01-84 10-05-84 49 FR 39307 11/5/1984 IV FLUDIAZEPAM 08-01-84 10-05-84 49 FR 39307 11/5/1984 IV FLUNITRAZEPAM 08-01-84 10-05-84 49 FR 39307 11/5/1984 IV CLOXAZOLAM 08-01-84 10-05-84 49 FR 39307 11/5/1984 IV HALOXAZOLAM 08-01-84 10-05-84 49 FR 39307 11/5/1984 IV KETAZOLAM 08-01-84 10-05-84 49 FR 39307 11/5/1984 IV CLOTIAZEPAM 08-01-84 10-05-84 49 FR 39307 11/5/1984 IV NIMETAZEPAM 08-01-84 10-05-84 49 FR 39307 11/5/1984 IV LOPRAZOLAM 08-01-84 10-05-84 49 FR 39307 11/5/1984 IV CLOBAZAM 08-01-84 10-05-84 49 FR 39307 11/5/1984 IV MEDAZEPAM 08-01-84 10-05-84 49 FR 39307 11/5/1984 IV CAMAZEPAM 08-01-84 10-05-84 49 FR 39307 11/5/1984 IV BROMAZEPAM 08-01-84 10-05-84 49 FR 39307 11/5/1984 IV BUPRENORPHINE 09-20-82 02-28-85 50 FR 8104 4/1/1985 II ￿- V 3-METHYLFENTANYL* 03-25-85 50 FR 11690 4/25/1985 I MDMA (3,4-METHYLENEDIOXYMETHAMPHETAMINE)* 05-31-85 50 FR 23118 7/1/1985 I MPPP* 07-10-85 50 FR 28098 8/12/1985 I PEPAP* 07-10-85 50 FR 28098 8/12/1985 I NALMEFENE 05-31-85 11-04-85 50 FR 45815 11/4/1985 II ￿- 0 BETA-HYDROXY-3-METHYLFENTANYL* 10-29-85 50 FR 43698 11/29/1985 I 3-METHYLTHIOFENTANYL* 10-29-85 50 FR 43698 11/29/1985 I Scheduling Actions -Chronological Order 27-Aug-21 Page 3 of 16 FINAL ORDER SUBSTANCE PROPOSAL FEDERAL *Scheduled under 21 USC 811(h) PUBLICATION PUBLICATION REGISTER EFFECTIVE CSA **Extension of temporary control DATE DATE CITATION DATE SCHEDULE THIOFENTANYL* 10-29-85 50 FR 43698 11/29/1985 I ACETYL-ALPHA-METHYLFENTANYL* 10-29-85 50 FR 43698 11/29/1985 I BENZYLFE

4 NTANYL* 10-29-85 50 FR 43698 11/29/19
NTANYL* 10-29-85 50 FR 43698 11/29/1985 I Expired 11/29/86 THENYLFENTANYL* 10-29-85 50 FR 43698 11/29/1985 I Expired 11/29/86 ALPHA-METHYLTHIOFENTANYL* 10-29-85 50 FR 43698 11/29/1985 I BETA-HYDROXYFENTANYL* 10-29-85 50 FR 43698 11/29/1985 I PARA-FLUOROFENTANYL* 02-07-86 51 FR 4722 3/10/1986 I QUAZEPAM 02-07-86 03-25-86 51 FR 10190 3/25/1986 IV MIDAZOLAM 02-07-86 03-25-86 51 FR 10190 3/25/1986 IV 3-METHYLFENTANYL** 04-24-86 51 FR 15474 4/25/1986 I DRONABINOL PRODUCT (MARINOL) 10-18-85 05-13-86 51 FR 17476 5/13/1986 I ￿- II MDMA (3,4-METHYLENEDIOXYMETHAMPHETAMINE)** 06-17-86 51 FR 21911 7/1/1986 I MPPP** 08-11-86 51 FR 28695 8/12/1986 I PEPAP** 08-11-86 51 FR 28695 8/12/1986 I 3-METHYLFENTANYL 04-24-86 09-22-86 51 FR 33592 9/22/1986 I MDMA (3,4-METHYLENEDIOXYMETHAMPHETAMINE) 07-27-84 10-14-86 51 FR 36552 11/13/1986 I ALPHA-METHYLTHIOFENTANYL** 11-26-86 51 FR 42834 11/29/1986 I 3-METHYLTHIOFENTANYL** 11-26-86 51 FR 42834 11/29/1986 I BETA-HYDROXY-3-METHYLFENTANYL** 11-26-86 51 FR 42834 11/29/1986 I Expired 5/29/87 BETA-HYDROXYFENTANYL** 11-26-86 51 FR 42834 11/29/1986 I THIOFENTANYL** 11-26-86 51 FR 42834 11/29/1986 I ACETYL-ALPHA-METHYLFENTANYL** 11-26-86 51 FR 42834 11/29/1986 I PEPAP 08-11-86 01-23-87 52 FR 2515 1/23/1987 I MPPP 08-11-86 01-23-87 52 FR 2515 1/23/1987 I ALFENTANIL 04-17-86 01-23-87 52 FR 2516 1/23/1987 I ￿- II TILETAMINE/ZOLAZEPAM (TELAZOL) 08-11-86 01-21-87 52 FR 2221 2/20/1987 III PARA-FLUOROFENTANYL** 03-10-87 52 FR 7270 3/10/1987 I NABILONE 06-18-86 04-07-87 52 FR 11042 4/7/1987 II 3-METHYLTHIOFENTANYL 11-28-86 05-29-87 52 FR 20070 5/29/1987 I BETA-HYDROXYFENTANYL 11-28-86 05-29-87 52 FR 20070 5/29/1987 I ALPHA-METHYLTHIOFENTANYL 11-28-86 05-29-87 52 FR 20070 5/29/1987 I PARA-FLUOROFENTANYL 03-10-87 05-29-87 52 FR 20070 5/29/1987 I ACETYL-ALPHA-METHYLFENTANYL 11-28-86 05-29-87 52 FR 20070 5/29/1987 I THIOFENTANYL 11-28-86 05-29-87 52 FR 20070 5/29/1987 I 4-METHYLAMINOREX* 10-15-87 52 FR 38225 10/15/1987 I 3,4-METHYLENEDIOXY-N-ETHYLAMPHETAMINE* 10-15-87 52 FR 38225 10/15/1987 I Scheduling Actions -Chronological Order 27-Aug-21 Page 4 of 16 FINAL ORDER SUBSTANCE PROPOSAL FEDERAL *Scheduled under 21 USC 811(h) PUBLICATION PUBLICATION REGISTER EFFECTIVE CSA **Extension of temporary control DATE DATE CITATION DATE SCHEDULE N-HYDROXY-3,4-METHYLENEDIOXYAMPHETAMINE* 10-15-87 52 FR 38225 10/15/1987 I BETA-HYDROXY-3-METHYLFENTANYL 11-28-86 01-08

5 -88 53 FR 500 1/8/1988 I MDMA (3,4-
-88 53 FR 500 1/8/1988 I MDMA (3,4-METHYLENEDIOXYMETHAMPHETAMINE) 01-27-88 53 FR 2225 1/27/1988 I ￿- 0 MDMA (3,4-METHYLENEDIOXYMETHAMPHETAMINE) 02-22-88 53 FR 5156 3/23/1988 I PYROVALERONE 10-30-87 04-04-88 53 FR 10869 5/4/1988 V PROPYLHEXEDRINE 10-30-87 04-04-88 53 FR 10869 5/4/1988 V MEFENOREX 10-30-87 05-17-88 53 FR 17459 6/16/1988 IV CATHINE 10-30-87 05-17-88 53 FR 17459 6/16/1988 IV FENCAMFAMIN 10-30-87 05-17-88 53 FR 17459 6/16/1988 IV FENPROPOREX 10-30-87 05-17-88 53 FR 17459 6/16/1988 IV N,N-DIMETHYLAMPHETAMINE* 08-03-88 53 FR 29232 8/3/1988 I 4-METHYLAMINOREX** 10-13-88 53 FR 40061 10/13/1988 I 3,4-METHYLENEDIOXY-N-ETHYLAMPHETAMINE** 10-13-88 53 FR 40061 10/13/1988 I N-HYDROXY-3,4-METHYLENEDIOXYAMPHETAMINE** 10-13-88 53 FR 40061 10/13/1988 I CARFENTANIL 01-12-88 10-28-88 53 FR 43684 10/28/1988 II N-HYDROXY-3,4-METHYLENEDIOXYAMPHETAMINE 10-14-88 04-13-89 54 FR 14797 4/13/1989 I 3,4-METHYLENEDIOXY-N-ETHYLAMPHETAMINE 10-14-88 04-13-89 54 FR 14797 4/13/1989 I 4-METHYLAMINOREX 10-14-88 04-13-89 54 FR 14799 4/13/1989 I 1-[1-(2-THIENYL)CYCLOHEXYL]PYRROLIDINE 03-20-89 07-06-89 54 FR 28414 7/6/1989 I N,N-DIMETHYLAMPHETAMINE** 08-02-89 54 FR 31815 8/2/1989 I N,N-DIMETHYLAMPHETAMINE 08-02-89 02-02-90 55 FR 3586 2/2/1990 I ANABOLIC STEROIDS PL 101-647 02-13-91 56 FR 5753 2/27/1991 III GLUTETHIMIDE 07-26-90 03-21-91 56 FR 11930 3/21/1991 III ￿- II PROPYLHEXEDRINE 12-03-91 56 FR 61372 12/3/1991 V -￿ 0 METHCATHINONE* 05-01-92 57 FR 18824 5/1/1992 I BUTORPHANOL, THEBAINE DERIVED 04-03-92 07-14-92 57 FR 31126 7/14/1992 II￿-0 Superseded 10/97 AMINOREX* 09-21-92 57 FR 43399 9/21/1992 I ZOLPIDEM 11-24-92 02-05-93 58 FR 7186 2/5/1993 IV 2,5-DIMETHOXY-4-ETHYLAMPHETAMINE (DOET) 10-30-87 01-14-93 58 FR 4316 2/16/1993 I CATHINONE 10-30-87 01-14-93 58 FR 4316 2/16/1993 I ALPHA-ETHYLTRYPTAMINE* 03-12-93 58 FR 13533 3/12/1993 I METHCATHINONE** 04-29-93 58 FR 25934 5/1/1993 I LEVO-ALPHACETYLMETHADOL (LAAM) 04-28-93 08-18-93 58 FR 43795 8/18/1993 I ￿- II AMINOREX** 08-24-93 58 FR 44611 9/21/1993 I METHCATHINONE 04-28-93 10-15-93 58 FR 53404 10/15/1993 I 4-BROMO-2,5-DIMETHOXYPHENETHYLAMINE* 01-06-94 59 FR 00671 1/6/1994 I Scheduling Actions -Chronological Order 27-Aug-21 Page 5 of 16 FINAL ORDER SUBSTANCE PROPOSAL FEDERAL *Scheduled under 21 USC 811(h) PUBLICATION PUBLICATION REGISTER EFFECTIVE CSA **Extension of temporary control DATE DATE CITATION DATE SCHED

6 ULE ALPHA-ETHYLTRYPTAMINE** 03-07-94
ULE ALPHA-ETHYLTRYPTAMINE** 03-07-94 59 FR 10720 3/12/1994 I AMINOREX 08-20-93 03-18-94 59 FR 12828 3/18/1994 I ALPHA-ETHYLTRYPTAMINE 03-07-94 09-12-94 59 FR 46757 9/12/1994 I 4-BROMO-2,5-DIMETHOXYPHENETHYLAMINE** 12-21-94 59 FR 65710 1/6/1995 I 4-BROMO-2,5-DIMETHOXYPHENETHYLAMINE 12-20-94 06-02-95 60 FR 28718 6/2/1995 I REMIFENTANIL 09-16-96 11-05-96 61 FR 56893 11/5/1996 II FENFLURAMINE 05-06-97 05-06-97 5/6/1997 IV ￿- 0 BUTORPHANOL 07-10-97 10-01-97 62 FR 51370 10/31/1997 IV SIBUTRAMINE 12-08-97 02-11-98 63 FR 6862 2/11/1998 IV MODAFINIL 04-14-98 01-27-99 64 FR 4050 1/27/1999 IV DRONABINOL PRODUCT (MARINOL) 11-05-98 07-02-99 64 FR 35928 7/2/1999 II ￿- III KETAMINE 04-09-99 07-13-99 64 FR 37673 8/12/1999 III ZALEPLON 05-05-99 09-15-99 64 FR 49982 9/15/1999 IV GAMMA HYDROXYBUTYRIC ACID (GHB) FDA approved drug PL 106-172 03-13-00 65 FR 13235 3/13/2000 III products GAMMA HYDROXYBUTYRIC ACID (GHB) PL 106-172 03-13-00 65 FR 13235 3/13/2000 I DIHYDROETORPHINE (thebaine derivative) 11-17-00 65 FR 69442 11/17/2000 clarification of CII control DICHLORALPHENAZONE (chloral hydrate compound) 12-11-00 08-16-01 66 FR 42943 8/16/2001 clarification of CIV control N-BENZYLPIPERAZINE (BZP) * 09-20-02 67 FR 59161 9/20/2002 I 1-(3-TRIFLUOROMETHYLPHENYL)PIPERAZINE (TFMPP) * 09-20-02 67 FR 59161 9/20/2002 I 2,5-DIMETHOXY-4-(n)-PROPYLTHIOPHENETHYLAMINE (2C - 09-20-02 67 FR 59163 9/20/2002 I T-7) * BUPRENORPHINE 03-21-02 10-07-02 67 FR 62354 10/7/2002 V -￿- III ALPHA-METHYLTRYPTAMINE (AMT) * 04-04-03 68 FR 16427 4/4/2003 I 5-METHOXY-N,N-DIISOPROPYLTRYPTAMINE (5-MeO-DIPT) * 04-04-03 68 FR 16427 4/4/2003 I FENFLURAMINE 05-15-03 68 FR 26247 5/15/2003 IV Withdrew 97 proposed rule 2,5-DIMETHOXY-4-(n)-PROPYLTHIOPHENETHYLAMINE (2C - 09-10-03 68 FR 53289 9/20/2003 I T-7) ** 1-(3-TRIFLUOROMETHYLPHENYL)PIPERAZINE (TFMPP) ** 09-10-03 68 FR 53289 9/20/2003 I N-BENZYLPIPERAZINE (BZP) ** 09-10-03 68 FR 53289 9/20/2003 I N-BENZYLPIPERAZINE (BZP) 09-08-03 03-18-04 69 FR 12794 3/18/2004 I 2,5-DIMETHOXY-4-(n)-PROPYLTHIOPHENETHYLAMINE (2C - 09-08-03 03-18-04 69 FR 12794 3/18/2004 I T-7) 1-(3-TRIFLUOROMETHYLPHENYL)PIPERAZINE (TFMPP) 09-08-03 03-18-04 69 FR 12794 3/19/2004 I ￿-- 0 Scheduling Actions -Chronological Order Page 6 of 16 27-Aug-21 FINAL ORDER SUBSTANCE PROPOSAL *Scheduled under 21 USC 811(h) PUBLICATION **Extension of temporary control DATE FEDERAL PUBLICATION REGISTER EFFECTIVE CSA DATE CITATION D

7 ATE SCHEDULE 5-METHOXY-N,N-DIISOPROPYL
ATE SCHEDULE 5-METHOXY-N,N-DIISOPROPYLTRYPTAMINE (5-MeO-DIPT) ** 04-01-04 69 FR 17034 4/1/2004 I ALPHA-METHYLTRYPTAMINE (AMT) ** 04-01-04 69 FR 17034 4/1/2004 I 5-METHOXY-N,N-DIISOPROPYLTRYPTAMINE (5-MeO-DIPT) 09-29-04 69 FR 58050 9/29/2004 I ALPHA-METHYLTRYPTAMINE (AMT) 09-29-04 69 FR 58050 9/29/2004 I ZOPICLONE 02-14-05 04-04-05 70 FR 16935 4/4/2005 IV PREGABALIN 05-12-05 07-28-05 70 FR 43633 7/28/2005 V ANABOLIC STEROIDS PL 108-358 12-16-05 70 FR 74653 1/17/2006 III EMBUTRAMIDE 07-29-05 08-29-06 71 FR 51115 9/28/2006 III LISDEXAMFETAMINE 02-22-07 05-03-07 72 FR 24532 6/4/2007 II ORIPAVINE 09-24-07 72 FR 54208 9/24/2007 II INDIPLON 01-31-08 01-31-08 1/31/2008 IV LACOSAMIDE 03-10-09 05-21-09 74 FR 23789 6/22/2009 V TAPENTADOL 02-17-09 05-21-09 74 FR 23790 6/22/2009 II FOSPROPOFOL 07-23-09 10-06-09 74 FR 51234 11/5/2009 IV 19-NOR-4,9(10)-ANDROSTADIENEDIONE (estra-4,9(10)-diene - 04-25-08 3,17-dione) 12-04-09 74 FR 63603 1/4/2010 III DESOXYMETHYLTESTOSTERONE (17a-methyl-5a-androst-2 - 04-25-08 en-17-ol, madol) 12-04-09 74 FR 63603 1/4/2010 III BOLDIONE (Androsta-1,4-diene-3,17-dione) 04-25-08 12-04-09 74 FR 63603 1/4/2010 III 4-ANILINO-N-PHENETHYL-4-PIPERIDINE (ANPP) 04-09-08 06-29-10 75 FR 37296 8/30/2010 II 5-METHOXY-N,N-DIMETHYLTRYPTAMINE 08-21-09 12-20-10 75 FR 79296 1/19/2011 I CP-47,497 * 03-01-11 76 FR 11075 3/1/2011 I JWH-018 * 03-01-11 76 FR 11075 3/1/2011 I CP-47,497 C8 HOMOLOGUE * 03-01-11 76 FR 11075 3/1/2011 I JWH-073 * 03-01-11 76 FR 11075 3/1/2011 I JWH-200 * 03-01-11 76 FR 11075 3/1/2011 I 3,4-METHYLENEDIOXY-N-METHYLCATHINONE (METHYLONE)* 10-21-11 76 FR 65371 10/21/2011 I 4-METHYL-N-METHYLCATHINONE (MEPHEDRONE)* 10-21-11 76 FR 65371 10/21/2011 I 3,4-METHYLENEDIOXYPYROVALERONE (MDPV)* 10-21-11 76 FR 65371 10/21/2011 I EZOGABINE 10-21-11 12-15-11 76 FR 77895 12/15/2011 V CARISOPRODOL 11-17-09 12-12-11 76 FR 77330 1/11/2012 IV CP-47,497 C8 HOMOLOGUE ** 02-29-12 77 FR 12201 2/29/2012 I JWH-073 ** 02-29-12 77 FR 12201 2/29/2012 I JWH-200 ** 02-29-12 77 FR 12201 2/29/2012 I JWH-018 ** 02-29-12 77 FR 12201 2/29/2012 I CP-47,497 ** 02-29-12 77 FR 12201 2/29/2012 I METHASTERONE ( 2 ALPHA-17 ALPHA-DIMETHYL-5 ALPHA - 11-23-11 ANDROSTAN-17BETA-OL-3-ONE) 07-30-12 77 FR 44456 8/29/2012 III Scheduling Actions -Chronological Order 27-Aug-21 Page 7 of 16 FINAL ORDER SUBSTANCE PROPOSAL FEDERAL *Scheduled under 21 USC 811(h) PUBLICATION PUBLICATION REGISTER EFFECT

8 IVE CSA **Extension of temporary contr
IVE CSA **Extension of temporary control DATE DATE CITATION DATE SCHEDULE PROSTANOZOL (17 BETA-HYDROXY-5 ALPHA - 11-23-11 07-30-12 77 FR 44456 8/29/2012 III ANDROSTANO[3,2-C]PRYAZOLE 3,4-METHYLENEDIOXY-N-METHYLCATHINONE 10-21-11 04-12-13 78 FR 21818 4/12/2013 I (METHYLONE) [1-(5-FLUORO-PENTYL)1H-INDOL-3-YL](2,2,3,3 - 05-16-13 78 FR 28735 5/16/2013 I TETRAMETHYLCYCLOPROPYL)METHANONE(5-FLUORO - UR-144, XLR11)* N-(1-ADAMANTYL)-1-PENTYL-1H-INDAZOLE-3 - 05-16-13 78 FR 28735 5/16/2013 I CARBOXAMIDE (APINACA, AKB48)* (1-PENTYL-1H-INDOL-3-YL)(2,2,3,3 - 05-16-13 78 FR 28735 5/16/2013 I TETRAMETHYLCYCLOPROPYL)METHANONE (UR-144)* LORCASERIN 12-19-12 05-08-13 78 FR 26701 6/7/2013 IV 2-(4-IODO-2,5-DIMETHOXYPHENYL)-N-(2-METHOXYBENZYL) 11-15-13 78 FR 68716 11/15/2013 I ETHANAMINE (25I-NBOMe)* 2-(4-CHLORO-2,5-DIMETHOXYPHENYL)-N-(2 - 11-15-13 78 FR 68716 11/15/2013 I METHOXYBENZYL) ETHANAMINE (25C-NBOMe)* 2-(4-BROMO-2,5-DIMETHOXYPHENYL)-N-(2 - 11-15-13 78 FR 68716 11/15/2013 I METHOXYBENZYL) ETHANAMINE (25B-NBOMe)* PERAMPANEL [2-(2-OXO-1-PHENYL - 10-22-13 12-02-13 78 FR 72013 1/2/2014 III 5-PYRIDIN-2-YL-l ,2-DIHYDROPYRIDIN-3-YL)BENZONITRILE ] N-(1-AMINO-3,3-DIMETHYL-1-OXOBUTAN-2-YL)-1-PENTYL - 02-10-14 79 FR 7577 2/10/2014 I 1H-INDAZOLE-3-CARBOXAMIDE (ADB-PINACA)* N-(1-AMINO-3-METHYL-1-OXOBUTAN-2-YL)-1-(4 - 02-10-14 79 FR 7577 2/10/2014 I FLUOROBENZYL)-1H-INDAZOLE-3-CARBOXAMIDE (AB - FUBINACA)* QUINOLIN-8-YL 1-PENTYL-1H-INDOLE-3-CARBOXYLATE 02-10-14 79 FR 7577 2/10/2014 I (PB–22;QUPIC)* QUINOLIN-8-YL 1-(5-FLUOROPENTYL)-1H-INDOLE-3 - 02-10-14 79 FR 7577 2/10/2014 I CARBOXYLATE( 5-FLUORO-PB–22;5F–PB–22)* BUTYLONE* 03-07-14 79 FR 12938 3/7/2014 I PENTYLONE* 03-07-14 79 FR 12938 3/7/2014 I NAPHYRONE* 03-07-14 79 FR 12938 3/7/2014 I ALPHA-PYRROLIDINOPENTIOPHENONE(α-PVP)* 03-07-14 79 FR 12938 3/7/2014 I ALPHA-PYRROLIDINOBUTIOPHENONE(α-PBP)* 03-07-14 79 FR 12938 3/7/2014 I 4-METHYL-N-ETHYLCATHINONE (4-MEC)* 03-07-14 79 FR 12938 3/7/2014 I 4-METHYL-ALPHAPYRROLIDINOPROPIOPHENONE (4 - 03-07-14 79 FR 12938 3/7/2014 I MePPP)* 4-FLUORO-N-METHYLCATHINONE (4-FMC)* 03-07-14 79 FR 12938 3/7/2014 I 3-FLUORO-N-METHYLCATHINONE (3-FMC)* 03-07-14 79 FR 12938 3/7/2014 I PENTEDRONE* 03-07-14 79 FR 12938 3/7/2014 I ALFAXALONE(5α-PREGNAN-3α-OL-11,20-DIONE) 03-25-13 02-27-14 79 FR 10985 3/31/2014 IV TRAMADOL (2-[(DIMETHYLAMINO)METHYL]-1-(3 - 11-04-13 07-02-14 79 FR 37623 8/18/2014 IV METHOXYPHENYL)CYCLOHEXANOL) SUVOREXANT 02-13-14 08-28-14 79 FR 52143 9/29/2014 IV HYDROCODONE COMBINATION PRODUCTS 02-27-14 08-22-14 79 FR 49661 10/6/2014 III￿-II Scheduling Actions -Chronological Order 27-Aug-21 Page 8 of 16

9
FINAL ORDER SUBSTANCE *Scheduled under 21 USC 811(h) **Extension of temporary control PROPOSAL PUBLICATION DATE PUBLICATION DATE FEDERAL REGISTER CITATION EFFECTIVE CSA DATE SCHEDULE NALOXEGEL 10-29-14 01-23-15 80 FR 3468 1/23/2015 II￿-0 N-(1-AMINO-3-METHYL - 1-OXOBUTAN-2-YL)-1-PENTYL-1H-INDAZOLE - 3-CARBOXAMIDE (AB-PINACA)* 01-30-15 80 FR 5042 1/30/2015 I [1-(5-FLUOROPENTYL)-1H-INDAZOL-3 - YL](NAPHTHALEN-1-YL)METHANONE (THJ-2201)* 01-30-15 80 FR 5042 1/30/2015 I N-(1-AMINO-3-METHYL-1 - OXOBUTAN-2-YL)1-(CYCLOHEXYLMETHYL) 1H-INDAZOLE-3-CARBOXAMIDE (AB-CHMINACA)* 01-30-15 80 FR 5042 1/30/2015 I ACETYL FENTANYL* (N-(1-PHENETHYLPIPERIDIN-4-YL)-N - PHENYLACETAMIDE) 07-17-15 80 FR 42381 7/17/2015 I ELUXADOLINE 08-11-15 11-12-15 80 FR 69861 12/17/2015 IV N-(1-AMINO-3,3DIMETHYL-1-OXOBUTAN-2-YL)1 - (CYCLOHEXYLMETHYL)-1H-INDAZOLE-3CARBOXAMIDE (MAB-CHMINACA)* 02-05-16 81 FR 6171 2/5/2016 I N-(1-AMINO-3-METHYL-1-OXOBUTAN-2-YL)-1-(4 - FLUOROBENZYL)-1H-INDAZOLE-3-CARBOXAMIDE FUBINACA)** (AB - 02-05-16 81 FR 6175 2/5/2016 I QUINOLIN-8-YL 1-(5-FLUOROPENTYL)-1H-INDOLE-3 - CARBOXYLATE( 5-FLUORO-PB–22;5F–PB–22)** 02-05-16 81 FR 6175 2/5/2016 I QUINOLIN-8-YL 1-PENTYL-1H-INDOLE-3-CARBOXYLATE (PB–22;QUPIC)** 02-05-16 81 FR 6175 2/5/2016 I N-(1-AMINO-3,3-DIMETHYL-1-OXOBUTAN-2-YL)-1-PENTYL - 1H-INDAZOLE-3-CARBOXAMIDE (ADB-PINACA)** 02-05-16 81 FR 6175 2/5/2016 I PENTEDRONE** 03-04-16 81 FR 11429 3/4/2016 I ALPHA-PYRROLIDINOPENTIOPHENONE(α-PVP)** 03-04-16 81 FR 11429 3/4/2016 I BUTYLONE** 03-04-16 81 FR 11429 3/4/2016 I 4-METHYL-N-ETHYLCATHINONE (4-MEC)** 03-04-16 81 FR 11429 3/4/2016 I 4-METHYL-ALPHAPYRROLIDINOPROPIOPHENONE (4 - MePPP)** 03-04-16 81 FR 11429 3/4/2016 I 4-FLUORO-N-METHYLCATHINONE (4-FMC)** 03-04-16 81 FR 11429 3/4/2016 I 3-FLUORO-N-METHYLCATHINONE (3-FMC)** 03-04-16 81 FR 11429 3/4/2016 I PENTYLONE** 03-04-16 81 FR 11429 3/4/2016 I ALPHA-PYRROLIDINOBUTIOPHENONE(α-PBP)** 03-04-16 81 FR 11429 3/4/2016 I NAPHYRONE** 03-04-16 81 FR 11429 3/4/2016 I BRIVARACETAM (BRV; UCB-34714; BRIVIACT) 05-12-16 81 FR 29487 5/12/2016 V BUTYRYL FENTANYL* 05-12-16 81 FR 29492 5/12/2016 I BETA-HYDROXYTHIOFENTANYL* 05-12-16 81 FR 29492 5/12/2016 I 3,4-DICHLORO-N-[(1 - DIMETHYLAMINO)CYCLOHEXYLMETHYL]BENZAMIDE) (AH-7921) 04-14-16 81 FR 22023 5/15/2016 I THIAFENTANIL 08-26-16 81 FR 58834 8/26/2016 II QUINOLIN-8-YL 1-(5-FLUOROPENTYL)-1H-INDOLE-3 - CARBOXYLATE (5-FLUORO-PB-22; 5F-PB-22) 09-06-16 81 FR 61130 9/6/2016 I Scheduling Actions -Chronological Order Page 9 of 16 27-Aug-21

10
FINAL ORDER SUBSTANCE PROPOSAL *Scheduled under 21 USC 811(h) PUBLICATION **Extension of temporary control DATE FEDERAL PUBLICATION REGISTER EFFECTIVE CSA DATE CITATION DATE SCHEDULE N-(1-AMINO-3-METHYL-1-OXOBUTAN-2-YL)-1-(4 - FLUOROBENZYL)-1H-INDAZOLE-3-CARBOXAMIDE (AB - FUBINACA) 09-06-16 81 FR 61130 9/6/2016 I QUINOLIN-8-YL 1-PENTYL-1H-INDOLE-3-CARBOXYLATE (PB - 22; QUPIC) 09-06-16 81 FR 61130 9/6/2016 I N-(1-AMINO-3,3-DIMETHYL-1-OXOBUTAN-2-YL)-1-PENTYL - 1H-INDAZOLE-3-CARBOXAMIDE (ADB-PINACA) 09-06-16 81 FR 61130 9/6/2016 I 3,4-DICHLORO-N-[2-(DIMETHYLAMINO)CYCLOHEXYL]-N - METHYLBENZAMIDE (U-47700)* 11-14-16 81 FR 79389 11/14/2016 I N-(1-PHENETHYLPIPERIDIN-4-YL)-N-PHENYLFURAN-2 - CARBOXAMIDE (FURANYL FENTANYL) * 11-29-16 81 FR 85873 11/29/2016 I ALPHA-PYRROLIDINOPENTIOPHENONE(α-PVP) 03-04-16 03-01-17 82 FR 12171 3/1/2017 I 4-METHYL-N-ETHYLCATHINONE (4-MEC) 03-04-16 03-01-17 82 FR 12171 3/1/2017 I NAPHYRONE 03-04-16 03-01-17 82 FR 12171 3/1/2017 I 3-FLUORO-N-METHYLCATHINONE (3-FMC) 03-04-16 03-01-17 82 FR 12171 3/1/2017 I 4-FLUORO-N-METHYLCATHINONE (4-FMC) 03-04-16 03-01-17 82 FR 12171 3/1/2017 I 4-METHYL-ALPHAPYRROLIDINOPROPIOPHENONE (4 - 03-04-16 MePPP) 03-01-17 82 FR 12171 3/1/2017 I ALPHA-PYRROLIDINOBUTIOPHENONE(α-PBP) 03-04-16 03-01-17 82 FR 12171 3/1/2017 I BUTYLONE 03-04-16 03-01-17 82 FR 12171 3/1/2017 I PENTYLONE 03-04-16 03-01-17 82 FR 12171 3/1/2017 I PENTEDRONE 03-04-16 03-01-17 82 FR 12171 3/1/2017 I DRONABINOL IN ORAL SOLUTION IN DRUG PRODUCT APPROVED FOR MARKETING BY U.S. FOOD AND DRUG ADMIN. 03-23-17 82 FR 14815 3/23/2017 II N-(ADAMANTAN-1-YL)-1-(5-FLUOROPENTYL)-1H-INDAZOLE - 3-CARBOXAMIDE(5F–APINACA,5F–AKB48)* 04-10-17 82 FR 17119 4/10/2017 I METHYL2-(1-(5-FLUOROPENTYL)-1H-INDAZOLE-3 - CARBOXAMIDO)-3-METHYLBUTANOATE (5F-AMB)* 04-10-17 82 FR 17119 4/10/2017 I METHYL 2-(1-(4-FLUOROBENZYL)-1H-INDAZOLE-3 - CARBOXAMIDO)-3,3-DIMETHYLBUTANOATE (MDMB–FUBINACA)* 04-10-17 82 FR 17119 4/10/2017 I METHYL 2-(1-(CYCLOHEXYLMETHYL)-1H-INDOLE-3 - CARBOXAMIDO)-3,3-DIMETHYLBUTANOATE (MDMB - CHMICA)* 04-10-17 82 FR 17119 4/10/2017 I N-(1-AMINO-3,3-DIMETHYL-1-OXOBUTAN-2-YL)-1-(4 - FLUOROBENZYL)1H-INDAZOLE-3-CARBOXAMIDE (ADB–FUBINACA)* 04-10-17 82 FR 17119 4/10/2017 I METHYL2-(1-(5-FLUOROPENTYL)-1H-INDAZOLE-3 - CARBOXAMIDO)-3,3-DIMETHYLBUTANOATE (5F-ADB)* 04-10-17 82 FR 17119 4/10/2017 I N-(4-FLUOROPHENYL)-N-(1-PHENETHYLPIPERIDIN-4 - YL)ISOBUTYRAMIDE (4-FLUOROISOBUTYRYL FENTANYL)* 05-03-17 82 FR 20544 5/3/2017 I ACETYL FENTANYL (N-(1-PHE

11 NETHYLPIPERIDIN-4-YL)-N - PHENYLACETAMID
NETHYLPIPERIDIN-4-YL)-N - PHENYLACETAMIDE) 06-07-17 82 FR 26349 6/7/2017 I ACRYL FENTANYL (N-(1-PHENETHYLPIPERIDIN-4-YL)-N - PHENYLACRYLAMIDE)* 07-14-17 82 FR 32453 7/14/2017 I Scheduling Actions -Chronological Order Page 10 of 16 27-Aug-21 FINAL ORDER SUBSTANCE *Scheduled under 21 USC 811(h) **Extension of temporary control PROPOSAL PUBLICATION DATE PUBLICATION DATE FEDERAL REGISTER CITATION EFFECTIVE CSA DATE SCHEDULE ORTHO-FLUOROFENTANYL OR 2-FLUOROFENTANYL (N-(2 - FLUOROPHENYL)-N-(1-PHENETHYLPIPERIDIN-4-YL))* 10-26-17 82 FR 49504 10/26/2017 I METHOXYACETYL FENTANYL (2-METHOXY-N-(1 - PHENETHYLPIPERIDIN-4-YL)-N-PHENYLACETAMIDE)* 10-26-17 82 FR 49504 10/26/2017 I TETRAHYDROFURANYL FENTANYL (N-(1 - PHENETHYLPIPERIDIN-4-YL)-N - PHENYLTETRAHYDROFURAN-2-CARBOXAMIDE)* 10-26-17 82 FR 49504 10/26/2017 I FUB–AMB,MMB–FUBINACA(METHYL 2-(1-(4 FLUOROBENZYL)-1HINDAZOLE-3-CARBOXAMIDO)-3 - METHYLBUTANOATE* 11-03-17 82 FR 51154 11/3/2017 I CYCLOPROPYL FENTANYL (N-(1-PHENETHYLPIPERIDIN-4 - YL)-N-PHENYLCYCLOPROPANECARBOXAMIDE)* 01-04-18 83 FR 469 1/4/2018 I MT-45 (1-CYCLOHEXYL-4-(1,2 - DIPHENYLETHYL)PIPERAZINE)) 12-13-17 82 FR 58557 1/12/2018 I N-(1-AMINO-3,3DIMETHYL-1-OXOBUTAN-2-YL)1 - (CYCLOHEXYLMETHYL)-1H-INDAZOLE - 3CARBOXAMIDE(MAB-CHMINACA)** 01-30-18 83 FR 4411 1/30/2018 I N-(2-FLUOROPHENYL)-2-METHOXY-N-(1 - PHENETHYLPIPERIDIN-4-YL)ACETAMIDE (OCFENTANIL)* 02-01-18 83 FR 4580 2/1/2018 I N-(1-PHENETHYLPIPERIDIN-4-YL)-N-PHENYLPENTANAMIDE (VALERYL FENTANYL)* 02-01-18 83 FR 4580 2/1/2018 I N-(4-FLUOROPHENYL)-N-(1-PHENETHYLPIPERIDIN-4 - YL)BUTYRAMIDE (PARA-FLUOROBUTYRYL FENTANYL)* 02-01-18 83 FR 4580 2/1/2018 I N-(4-METHOXYPHENYL)-N-(1-PHENETHYLPIPERIDIN-4 - YL)BUTYRAMIDE (PARA-METHOXYBUTYRYL FENTANYL)* 02-01-18 83 FR 4580 2/1/2018 I N-(4-CHLOROPHENYL)-N-(1-PHENETHYLPIPERIDIN-4 - YL)ISOBUTYRAMIDE (PARA-CHLOROISOBUTYRYL FENTANYL)* 02-01-18 83 FR 4580 2/1/2018 I N-(1-PHENETHYLPIPERIDIN-4-YL)-N - PHENYLISOBUTYRAMIDE (ISOBUTYRYL FENTANYL)* 02-01-18 83 FR 4580 2/1/2018 I N-(1-PHENETHYLPIPERIDIN-4-YL)-N - PHENYLCYCLOPENTANECARBOXAMIDE (CYCLOPENTYL FENTANYL)* 02-01-18 83 FR 4580 2/1/2018 I FENTANYL-RELATED SUBSTANCES, AS DEFINED IN 21 CFR 1308.11(h)* 02-06-18 83 FR 5188 2/6/2018 I 3,4-DICHLORO-N-[2-(DIMETHYLAMINO)CYCLOHEXYL]-N - METHYLBENZAMIDE (U-47700) 04-20-18 83 FR 17486 4/20/2018 I N-(1-PHENETHYLPIPERIDIN-4-YL)-N - PHENYLBUTANAMIDE (BUTYRYL FENTANYL) 04-20-18 83 FR 17486 4/20/2018 I 1-(5-FLUOROPENTYL)-N-(2-PHENYLPROPAN-2-YL)-1 H - PYRROLO[2,3-B]PYRIDINE-3-CARBOXAMIDE(5FCUMYL -

12 P7AICA)* 07-10-18 83 FR 31877 7/10/2
P7AICA)* 07-10-18 83 FR 31877 7/10/2018 I NAPHTHALEN-1-YL 1-(5-FLUOROPENTYL)-1 H-INDOLE-3 - CARBOXYLATE (NM2201; CBL2201)* 07-10-18 83 FR 31877 7/10/2018 I N-(1-AMINO-3-METHYL-1-OXOBUTAN-2-YL)-1-(5 - FLUOROPENTYL)-1 H-INDAZOLE-3-CARBOXAMIDE (5F-AB - PINACA)* 07-10-18 83 FR 31877 7/10/2018 I 1-(4-CYANOBUTYL)-N-(2-PHENYLPROPAN-2-YL)-1 H - INDAZOLE-3-CARBOXAMIDE (4-CN-CUMYL-BUTINACA)* 07-10-18 83 FR 31877 7/10/2018 I Scheduling Actions -Chronological Order Page 11 of 16 27-Aug-21 FINAL ORDER SUBSTANCE PROPOSAL *Scheduled under 21 USC 811(h) PUBLICATION **Extension of temporary control DATE FEDERAL PUBLICATION REGISTER EFFECTIVE CSA DATE CITATION DATE SCHEDULE METHYL 2-(1-(CYCLOHEXYLMETHYL)-1 H-INDOLE-3 - CARBOXAMIDO)-3-METHYLBUTANOATE (MMB-CHMICA, AMB-CHMICA)* 07-10-18 83 FR 31877 7/10/2018 I 1-(1,3-BENZODIOXOL-5-YL)-2-(ETHYLAMINO)-PENTAN-1 - ONE (N-ETHYLPENTYLONE, EPHYLONE)* 08-31-18 83 FR 44474 8/31/2018 I APPROVED CANNABIDIOL DRUGS , AS DEFINED IN 21 CFR 1308.15(f) 09-28-18 83 FR 48953 9/28/2018 V ACRYL FENTANYL (N-(1-PHENETHYLPIPERIDIN-4-YL)-N - PHENYLACRYLAMIDE) 11-29-18 83 FR 61320 11/29/2018 I TETRAHYDROFURANYL FENTANYL (N-(1 - PHENETHYLPIPERIDIN-4-YL)-N - PHENYLTETRAHYDROFURAN-2-CARBOXAMIDE) 11-29-18 83 FR 61320 11/29/2018 I N-(4-FLUOROPHENYL)-N-(1-PHENETHYLPIPERIDIN-4 - YL)ISOBUTYRAMIDE (4-FLUOROISOBUTYRYL FENTANYL) 11-29-18 83 FR 61320 11/29/2018 I N-(1-PHENETHYLPIPERIDIN-4-YL)-N-PHENYLFURAN-2 - CARBOXAMIDE (FURANYL FENTANYL) 11-29-18 83 FR 61320 11/29/2018 I N-(2-FLUOROPHENYL)-2-METHOXY-N-(1 - PHENETHYLPIPERIDIN-4-YL)ACETAMIDE (OCFENTANIL) 11-29-18 83 FR 61320 11/29/2018 I N-(1-AMINO-3,3DIMETHYL-1-OXOBUTAN-2-YL)1 - (CYCLOHEXYLMETHYL)-1H-INDAZOLE-3CARBOXAMIDE (MAB-CHMINACA) 01-29-19 84 FR 444 1/29/2019 I METHYL 2-(1-(5-FLUOROPENTYL)-1H-INDAZOLE - 3CARBOXAMIDO)3,3-DIMETHYLBUTANOATE(5F-ADB, 5FMDMB-PINACA)** 04-08-19 84 FR 13796 4/8/2019 I METHYL2-(1-(5-FLUOROPENTYL)-1H-INDAZOLE-3 - CARBOXAMIDO)-3-METHYLBUTANOATE (5F-AMB)** 04-08-19 84 FR 13796 4/8/2019 I N-(ADAMANTAN-1-YL)-1-(5-FLUOROPENTYL)-1H-INDAZOLE - 3-CARBOXAMIDE (5F-APINACA, 5F-AKB48)** 04-08-19 84 FR 13796 4/8/2019 I METHYL 2-(1-(4-FLUOROBENZYL)-1HINDAZOLE-3 - CARBOXAMIDO)-3,3-DIMETHYLBUTANOATE (MDMB - FUBINACA)** 04-08-19 84 FR 13796 4/8/2019 I N-(1-AMINO-3,3-DIMETHYL-1-OXOBUTAN-2-YL)-1-(4 - FLUOROBENZYL)1H-INDAZOLE-3 - CARBOXAMIDE(ADB–FUBINACA)** 04-08-19 84 FR 13796 4/8/2019 I METHYL 2-(1-(CYCLOHEXYLMETHYL)-1H-INDOLE-3 - CARBOXAMIDO)-3,3-DIMETHYLBUTANOATE (MDMB - CHMICA)** 04-08-19 84 F

13 R 13796 4/8/2019 I (1-(4-FLUOROBENZYL
R 13796 4/8/2019 I (1-(4-FLUOROBENZYL)-1H-INDOL-3-YL)(2,2,3,3 - TETRAMETHYLCYCLOPROPYL)METHANONE * (FUB-144) 04-16-19 84 FR 15505 4/16/2019 I 1-(5-FLUOROPENTYL)-N-(2-PHENYLPROPAN-2-YL)-1H - INDAZOLE-3-CARBOXAMIDE * (5F-CUMYL-PINACA; SGT-25) 04-16-19 84 FR 15505 4/16/2019 I N-(ADAMANTAN-1-YL)-1-(4-FLUOROBENZYL)-1H-INDAZOLE - 3-CARBOXAMIDE * (FUB-AKB48; FUB-APINACA) 04-16-19 84 FR 15505 4/16/2019 I METHYL 2-(1-(5-FLUOROPENTYL)-1H-INDOLE-3 - CARBOXAMIDO)-3,3-DIMETHYLBUTANOATE * (5F-MDMB - PICA) 04-16-19 84 FR 15505 4/16/2019 I ETHYL 2-(1-(5-FLUOROPENTYL)-1H-INDAZOLE-3 - CARBOXAMIDO)-3,3-DIMETHYLBUTANOATE * (5F-EDMB - PINACA) 04-16-19 84 FR 15505 4/16/2019 I BETA-HYDROXYTHIOFENTANYL 05-08-19 84 FR 20023 5/8/2019 I Scheduling Actions -Chronological Order Page 12 of 16 27-Aug-21 FINAL ORDER SUBSTANCE *Scheduled under 21 USC 811(h) **Extension of temporary control PROPOSAL PUBLICATION DATE PUBLICATION DATE FEDERAL REGISTER CITATION EFFECTIVE CSA DATE SCHEDULE BREXANOLONE(3Α-HYDROXY-5Α-PREGNAN-20-ONE), ALLOPREGNANOLONE 06-17-19 84 FR 27938 6/17/2019 IV SOLRIAMFETOL (2-AMINO-3-PHENYLPROPYL CAR - BAMATE; BENZENEPROPANOL,BETA-AMINO-, CARBAMATE (ESTER)) 06-17-19 84 FR 27943 6/17/2019 IV 4´-METHYL-ALPHA-PYRROLIDINOHEXIOPHENONE* (MPHP) 07-18-19 84 FR 34291 7/18/2019 I 4-CHLORO-ALPHA-PYRROLIDINOVALEROPHENONE * (4 - CHLORO-A-PVP) 07-18-19 84 FR 34291 7/18/2019 I N-ETHYLHEXEDRONE * 07-18-19 84 FR 34291 7/18/2019 I ALPHA-PYRROLIDINOHEPTAPHENONE* (PV8) 07-18-19 84 FR 34291 7/18/2019 I 4-METHYL-ALPHA-ETHYLAMINOPENTIOPHENONE * (4 - MEAP) 07-18-19 84 FR 34291 7/18/2019 I ALPHA-PYRROLIDINOHEXANOPHENONE * (A-PHP) 07-18-19 84 FR 34291 7/18/2019 I N-(4-FLUOROPHENYL)-N-(1-PHENETHYLPIPERIDIN-4 - YL)BUTYRAMIDE (PARA-FLUOROBUTYRYL FENTANYL) 10-25-19 84 FR 57323 10/25/2019 I ORTHO-FLUOROFENTANYL OR 2-FLUOROFENTANYL (N-(2 - FLUOROPHENYL)-N-(1-PHENETHYLPIPERIDIN-4-YL)) 10-25-19 84 FR 57323 10/25/2019 I METHOXYACETYL FENTANYL (2-METHOXY-N-(1 - PHENETHYLPIPERIDIN-4-YL)-N-PHENYLACETAMIDE) 10-25-19 84 FR 57323 10/25/2019 I CYCLOPROPYL FENTANYL (N-(1-PHENETHYLPIPERIDIN-4 - YL)-N-PHENYLCYCLOPROPANECARBOXAMIDE) 10-25-19 84 FR 57323 10/25/2019 I FUB–AMB,MMB–FUBINACA(METHYL 2-(1-(4 FLUOROBENZYL)-1HINDAZOLE-3-CARBOXAMIDO)-3 - METHYLBUTANOATE** 10-30-19 84 FR 58045 11/3/2019 I METHYL 2-(1-(5-FLUOROPENTYL)-1H-INDAZOLE-3 - CARBOXAMIDO)3,3-DIMETHYLBUTANOATE(5F-ADB, 5FMDMB-PINACA) 01-24-20 85 FR 4211 1/24/2020 I METHYL 2-(1-(5-FLUOROPENTYL)-1H-INDAZOLE-3 - CARBOXAMIDO)-3-METHYLBUTANOAT

14 E (5FAMB) 01-24-20 85 FR 4211 1/24/20
E (5FAMB) 01-24-20 85 FR 4211 1/24/2020 I N-(ADAMANTAN-1-YL)-1-(5-FLUOROPENTYL)-1H-INDAZOLE - 3-CARBOXAMIDE (5F-APINACA, 5F-AKB48) 01-24-20 85 FR 4211 1/24/2020 I N-(1-AMINO-3,3-DIMETHYL-1-OXOBUTAN-2-YL)-1-(4 - FLUOROBENZYL)-1H-INDAZOLE-3-CARBOXAMIDE (ADB - FUBINACA) 01-24-20 85 FR 4211 1/24/2020 I METHYL 2-(1-(4-FLUOROBENZYL)-1HINDAZOLE-3 - CARBOXAMIDO)-3,3-DIMETHYLBUTANOATE (MDMB - FUBINACA) 01-24-20 85 FR 4211 1/24/2020 I METHYL 2-(1-(CYCLOHEXYLMETHYL)-1H-INDOLE-3 - CARBOXAMIDO)-3,3-DIMETHYLBUTANOATE (MDMB - CHMICA) 01-24-20 85 FR 4211 1/24/2020 I 6β-NALTREXOL ((5a,6β)-17-(CYCLOPROPYLMETHYL)-4,5 EPOXYMORPHINAN-3,6,14-TRIOL) 01-24-20 85 FR 4215 1/24/2020 II ￿- 0 LASMIDITAN [2,4,6-TRIFLUORO-N-(6-(1-METHYLPIPERIDINE - 4-CARBONYL)PYRIDINE-2-YL-BENZAMIDE] 01-31-20 85 FR 5557 1/31/2020 V N-(1-PHENETHYLPIPERIDIN-4-YL)-N-PHENYLPENTANAMIDE (VALERYL FENTANYL)** 01-30-20 85 FR 5321 2/1/2020 I N-(4-CHLOROPHENYL)-N-(1-PHENETHYLPIPERIDIN-4 - YL)ISOBUTYRAMIDE (PARA-CHLOROISOBUTYRYL FENTANYL)** 01-30-20 85 FR 5321 2/1/2020 I Scheduling Actions -Chronological Order 27-Aug-21 Page 13 of 16 FINAL ORDER SUBSTANCE PROPOSAL *Scheduled under 21 USC 811(h) PUBLICATION **Extension of temporary control DATE FEDERAL PUBLICATION REGISTER EFFECTIVE CSA DATE CITATION DATE SCHEDULE N-(1-PHENETHYLPIPERIDIN-4-YL)-N - PHENYLISOBUTYRAMIDE (ISOBUTYRYL FENTANYL)** 01-30-20 85 FR 5321 2/1/2020 I N-(4-METHOXYPHENYL)-N-(1-PHENETHYLPIPERIDIN-4 - YL)BUTYRAMIDE (PARA-METHOXYBUTYRYL FENTANYL)** 01-30-20 85 FR 5321 2/1/2020 I N-(1-PHENETHYLPIPERIDIN-4-YL)-N - PHENYLCYCLOPENTANECARBOXAMIDE (CYCLOPENTYL FENTANYL)** 01-30-20 85 FR 5321 2/1/2020 I CENOBAMATE [(1R)-1-(2-CHLOROPHENYL)-2-(TETRAZOL-2 - YL)ETHYL]CARBAMATE 03-10-20 85 FR 13741 3/10/2020 V FUB–AMB,MMB–FUBINACA(METHYL 2-(1-(4 FLUOROBENZYL)-1HINDAZOLE-3-CARBOXAMIDO)-3 - METHYLBUTANOATE 03-30-20 85 FR 17494 3/30/2020 I LEMBOREXANT 04-07-20 85 FR 19387 4/7/2020 IV NORFENTANYL (N-PHENYL-N-(PIPERIDIN-4-YL) 09-17-19 PROPIONAMIDE) 04-17-20 85 FR 21320 5/18/2020 II METHYL 2-(1-(CYCLOHEXYLMETHYL)-1H-INDOLE-3 - CARBOXAMIDO)-3-METHYLBUTANOATE (MMB-CHMICA, AMB-CHMICA)** 07-13-20 85 FR 42296 7/10/2020 I 1-(4-CYANOBUTYL)-N-(2-PHENYLPROPAN-2-YL)-1 H - INDAZOLE-3-CARBOXAMIDE (4-CN-CUMYL-BUTINACA)** 07-13-20 85 FR 42296 7/10/2020 I N-(1-AMINO-3-METHYL-1-OXOBUTAN-2-YL)-1-(5 - FLUOROPENTYL)-1 H-INDAZOLE-3-CARBOXAMIDE (5F-AB - PINACA)** 07-13-20 85 FR 42296 7/10/2020 I NAPHTHALEN-1-YL 1-(5-FLUOROPENTYL)-1 H-INDOLE-3 - CARBOXYLATE (NM2201; CBL2201)** 07-13-20 85 FR

15 42296 7/10/2020 I 1-(5-FLUOROPENTYL)-
42296 7/10/2020 I 1-(5-FLUOROPENTYL)-N-(2-PHENYLPROPAN-2-YL)-1H - PYRROLO[2,3-B]PYRIDINE-3-CARBOXAMIDE(5FCUMYL - P7AICA)** 07-13-20 85 FR 42296 7/10/2020 I ISOTONITAZENE (N,N-DIETHYL-2-(2-(4 ISOPROPOXYBENZYL)-5-NITRO-1H-BENZIMIDAZOL-1 - YL)ETHAN-1-AMINE)* 08-20-20 85 FR 51342 8/20/2020 I 1-(1,3-BENZODIOXOL-5-YL)-2-(ETHYLAMINO)-PENTAN-1 - ONE (N-ETHYLPENTYLONE, EPHYLONE)** 08-27-20 85 FR 52915 8/31/2020 I CROTONYL FENTANYL ((E)-N-(1-PHENETHYLPIPERIDIN-4 - YL)-N-PHENYLBUT-2-ENAMIDE) 10-02-20 85 FR 62215 10/2/2020 I REMIMAZOLAM (4H-IMIDAZOL[1,2-A][1,4]BENZODIAZEPINE - 4-PROPIONIC ACID) 10-06-20 85 FR 63014 10/6/2020 IV OLICERIDINE 10-30-20 85 FR 68749 10/30/2020 II 11/25/2020 N-(4-METHOXYPHENYL)-N-(1-PHENETHYLPIPERIDIN-4 - YL)BUTYRAMIDE (PARA-METHOXYBUTYRYL FENTANYL) 11-25-20 85 FR 75231 11/25/2020 I N-(1-PHENETHYLPIPERIDIN-4-YL)-N-PHENYLPENTANAMIDE (VALERYL FENTANYL) 11-25-20 85 FR 75231 11/25/2020 I N-(4-CHLOROPHENYL)-N-(1-PHENETHYLPIPERIDIN-4 - YL)ISOBUTYRAMIDE (PARA-CHLOROISOBUTYRYL FENTANYL) 11-25-20 85 FR 75231 11/25/2020 I N-(1-PHENETHYLPIPERIDIN-4-YL)-N - PHENYLISOBUTYRAMIDE (ISOBUTYRYL FENTANYL) 11-25-20 85 FR 75231 11/25/2020 I Scheduling Actions -Chronological Order Page 14 of 16 27-Aug-21 FINAL ORDER SUBSTANCE PROPOSAL *Scheduled under 21 USC 811(h) PUBLICATION **Extension of temporary control DATE FEDERAL PUBLICATION REGISTER EFFECTIVE CSA DATE CITATION DATE SCHEDULE N-(1-PHENETHYLPIPERIDIN-4-YL)-N - PHENYLCYCLOPENTANECARBOXAMIDE (CYCLOPENTYL FENTANYL) 11-25-20 85 FR 75231 11/25/2020 I 1-(1-(1-(4-BROMOPHENYL)ETHYL)PIPERIDIN-4-YL)-1,3 - DIHYDRO-2H-BENZO[D]IMIDAZOL-2-ONE (BRORPHINE)* 03-01-21 86 FR 11862 3/1/2021 I 1-(5-FLUOROPENTYL)-N-(2-PHENYLPROPAN-2-YL)-1H - INDAZOLE-3-CARBOXAMIDE ** (5F-CUMYL-PINACA; SGT - 25) 03-31-21 86 FR 16669 4/16/2021 I (1-(4-FLUOROBENZYL)-1H-INDOL-3-YL)(2,2,3,3 - TETRAMETHYLCYCLOPROPYL)METHANONE ** (FUB-144) 03-31-21 86 FR 16669 4/16/2021 I N-(ADAMANTAN-1-YL)-1-(4-FLUOROBENZYL)-1H-INDAZOLE - 3-CARBOXAMIDE ** (FUB-AKB48; FUB-APINACA) 03-31-21 86 FR 16669 4/16/2021 I METHYL 2-(1-(5-FLUOROPENTYL)-1H-INDOLE-3 - CARBOXAMIDO)-3,3-DIMETHYLBUTANOATE ** (5F-MDMB - PICA) 03-31-21 86 FR 16669 4/16/2021 I ETHYL 2-(1-(5-FLUOROPENTYL)-1H-INDAZOLE-3 - CARBOXAMIDO)-3,3-DIMETHYLBUTANOATE ** (5F-EDMB - PINACA) 03-31-21 86 FR 16669 4/16/2021 I SAMIDORPHAN 04-19-21 86 FR 20284 4/19/2021 II ￿- 0 PHENYL FENTANYL 04-27-21 86 FR 22113 4/27/2021 I PARA-METHYLFENTANYL 04-27-21 86 FR 22113 4/27/2021 I THIOFURANYL FENTANYL 04-27-21 86 FR 22

16 113 4/27/2021 I BETA-METHYL FENTANYL
113 4/27/2021 I BETA-METHYL FENTANYL 04-27-21 86 FR 22113 4/27/2021 I BETA'-PHENYL FENTANYL 04-27-21 86 FR 22113 4/27/2021 I 2'-FLUORO ORTHO-FLUOROFENTANYL 04-27-21 86 FR 22113 4/27/2021 I 4'-METHYL ACETYL FENTANYL 04-27-21 86 FR 22113 4/27/2021 I ORTHO-FLUOROBUTYRYL FENTANYL 04-27-21 86 FR 22113 4/27/2021 I ORTHO-METHYL ACETYLFENTANYL 04-27-21 86 FR 22113 4/27/2021 I ORTHO-METHYL METHOXYACETYL FENTANYL 04-27-21 86 FR 22113 4/27/2021 I ORTHO-FLUOROACRYL FENTANYL 05-04-21 86 FR 23602 5/4/2021 I FENTANYL CARBAMATE 05-04-21 86 FR 23602 5/4/2021 I ORTHO-FLUOROISOBUTYRYL FENTANYL 05-04-21 86 FR 23602 5/4/2021 I PARA-FLUORO FURANYL FENTANYL 05-04-21 86 FR 23602 5/4/2021 I SERDEXMETHYLPHENIDATE 05-07-21 86 FR 24487 5/7/2021 IV 1-(5-FLUOROPENTYL)-N-(2-PHENYLPROPAN-2-YL)-1 H - PYRROLO[2,3-B]PYRIDINE-3-CARBOXAMIDE(5FCUMYL - P7AICA) 06-10-21 86 FR 30775 6/10/2021 I NAPHTHALEN-1-YL 1-(5-FLUOROPENTYL)-1 H-INDOLE-3 - CARBOXYLATE (NM2201; CBL2201) 06-10-21 86 FR 30775 6/10/2021 I N-(1-AMINO-3-METHYL-1-OXOBUTAN-2-YL)-1-(5 - FLUOROPENTYL)-1 H-INDAZOLE-3-CARBOXAMIDE (5F-AB - PINACA) 06-10-21 86 FR 30775 6/10/2021 I 1-(4-CYANOBUTYL)-N-(2-PHENYLPROPAN-2-YL)-1 H - INDAZOLE-3-CARBOXAMIDE (4-CN-CUMYL-BUTINACA) 06-10-21 86 FR 30775 6/10/2021 I Scheduling Actions -Chronological Order Page 15 of 16 27-Aug-21 FINAL ORDER SUBSTANCE *Scheduled under 21 USC 811(h) **Extension of temporary control PROPOSAL PUBLICATION DATE PUBLICATION DATE FEDERAL REGISTER CITATION EFFECTIVE CSA DATE SCHEDULE METHYL 2-(1-(CYCLOHEXYLMETHYL)-1 H-INDOLE-3 - CARBOXAMIDO)-3-METHYLBUTANOATE (MMB-CHMICA, AMB-CHMICA) 06-10-21 86 FR 30775 6/10/2021 I 1-(1,3-BENZODIOXOL-5-YL)-2-(ETHYLAMINO)-PENTAN-1 - ONE (N-ETHYLPENTYLONE, EPHYLONE) 06-14-21 86 FR 31427 6/14/2021 I N-ETHYLHEXEDRONE ** 07-18-21 86 FR 37672 7/18/2021 I ALPHA-PYRROLIDINOHEPTAPHENONE** (PV8) 07-18-21 86 FR 37672 7/18/2021 I 4´-METHYL-ALPHA-PYRROLIDINOHEXIOPHENONE** (MPHP) 07-18-21 86 FR 37672 7/18/2021 I 4-METHYL-ALPHA-ETHYLAMINOPENTIOPHENONE ** (4 - MEAP) 07-18-21 86 FR 37672 7/18/2021 I ALPHA-PYRROLIDINOHEXANOPHENONE ** (A-PHP) 07-18-21 86 FR 37672 7/18/2021 I 4-CHLORO-ALPHA-PYRROLIDINOVALEROPHENONE ** (4 - CHLORO-A-PVP) 07-18-21 86 FR 37672 7/18/2021 I PARA-METHOXYMETHAMPHETAMINE (PMMA), 1-(4 - METHOXYPHENYL)-N-METHYLPROPAN-2-AMINE 05-15-20 06-25-21 86 FR 33508 7/26/2021 I 4,4 ′-DIMETHYLAMINOREX(4,4′-DMAR;4,5-DIHYDRO-4 METHYL-5-(4-METHYLPHENYL)-2-OXAZOLAMINE) 04-07-20 08-12-21 86 FR 44270 9/13/2021 I Scheduling Actions -Chronological Order Page 16 of 16 27-